Related Experiment Video
Updated: Jun 29, 2025

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
3.7K
Primary Thyroid Lymphoma: A Retrospective-Observational Study in a Single Institutional Center
Octavia Vita1, Alis Dema1,2, Robert Barna1
1Department of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Medicina (Kaunas, Lithuania)
|March 28, 2024
Summary
Primary thyroid lymphoma (PTL) is a rare cancer. Diagnosis is challenging, but PTL often has a favorable outcome, especially in younger patients with Hashimoto
Area of Science:
- Oncology
- Pathology
- Endocrinology
Background:
- Primary thyroid lymphoma (PTL) is a rare neoplasm with diverse histological presentations.
- Accurate diagnosis of PTL can be challenging for pathologists.
- PTL often presents as a progressive, painless cervical mass, potentially with compressive symptoms.
Purpose of the Study:
- To analyze the clinical and pathological characteristics of primary thyroid lymphoma.
- To identify key features associated with PTL diagnosis and prognosis.
- To evaluate survival rates and influencing factors in PTL patients.
Main Methods:
- Retrospective analysis of clinical and pathological data from eleven PTL patients.
- Histological classification of PTL subtypes.
- Assessment of disease stage and patient survival.
Main Results:
- Diffuse large B-cell lymphoma was the most common subtype (55%).
- PTL was frequently associated with microscopic Hashimoto autoimmune thyroiditis (90.9%).
- Localized disease (Stage I-IIE) was observed in 90.9% of patients, with a 5-year survival rate of 60%.
Conclusions:
- PTL should be considered in women with Hashimoto's thyroiditis presenting with progressive cervical tumors.
- PTL is a lymphoid neoplasm with a generally favorable prognosis.
- Younger age (<70 years) is associated with longer survival in PTL patients.
Keywords:
Hashimoto thyroiditisfine needle aspiratenon-Hodgkin B-cell lymphomasprimary thyroid lymphomasurvival
